Cell Signaling Unpacked: GPCRs, RTKs, and the Kinome

Explore how cells translate external signals into rapid biological responses. This lecture explains the two main intracellular switches, G proteins and phosphorylation, and how GPCRs and receptor tyrosine kinases drive amplification and specificity in signaling pathways.

Overview of Cellular Signaling

The video introduces cellular signaling as a dynamic, multi-step process that starts with an extracellular signal and ends in a cellular or organismal response. It emphasizes two core switches that control signaling dynamics: G proteins and phosphorylation.

G Protein Coupled Receptors and G Proteins

GPCRs are membrane-spanning receptors that bind ligands outside the cell and transduce the signal to the inside via G proteins. In the fight or flight example, adrenaline binds to a GPCR, causing the alpha subunit of a trimeric G protein to exchange GDP for GTP and activate. The active GTP-bound alpha subunit then engages adenylate cyclase to generate cyclic AMP from ATP, producing a second messenger that amplifies the signal. The cascade exemplifies amplification and the speed of signaling, as one signal can lead to dozens of second messengers and activated enzymes. cAMP activates protein kinase A, a serine/threonine kinase, which phosphorylates multiple substrates to drive the metabolic response, such as glycogen breakdown in the liver. The system is tightly regulated by phosphodiesterases that degrade cAMP and other phosphatases that reverse phosphorylation.

Kinases and Phosphatases

The lecture highlights phosphorylation as a major post translational modification, adding a phosphate mainly to serine, threonine or tyrosine residues. Kinases use ATP as the phosphate donor, while phosphatases remove phosphate groups. The kinome, a collective term for the full complement of protein kinases in the genome, includes around five hundred kinases, with hundreds of phosphatases, showing how central phosphorylation is to signaling. Tyrosine kinases are featured as extracellular to intracellular signaling players that form an important family for many pathways.

Receptor Tyrosine Kinases and RTK Signaling

RTKs are single-pass membrane proteins with extracellular ligand-binding domains and intracellular kinase domains. Upon ligand binding, RTKs dimerize and activate by trans-phosphorylation of their kinase domains. This creates docking sites for downstream signaling proteins, including the small GTPase Ras, which becomes Ras-GTP and triggers kinase cascades that propagate signals to the nucleus to influence gene expression and cell proliferation. The RTK examples illustrate how phosphorylation networks drive complex cellular outcomes beyond immediate cytoplasmic events.

Integration, Targets, and Disease Relevance

Signaling networks show integration and cross talk between pathways, enabling graded or switch-like responses. Mutations can cause constitutive activation, where a receptor or kinase remains on without a signal, contributing to diseases such as cancer or inflammation. The talk notes that GPCRs and kinases are major drug targets, with many therapeutics (small molecules and monoclonal antibodies) designed to inhibit dysregulated signaling. The kinase inhibitors and GPCR-targeting drugs illustrate how understanding molecular switches translates into medical advances.

Takeaway

Understanding the molecular switches that govern signaling, the architecture of GPCR and RTK pathways, and the dynamics of amplification and feedback provides a framework to analyze how cells respond to signals, how these signals are integrated with others, and why these pathways are central to health and disease.